Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pathology · Cellular Schwannoma

What Does Cellular Schwannoma Mean on a Pathology Report?

At a Glance

Cellular schwannoma on a pathology report means a rare benign nerve tumor made of densely packed Schwann cells, not a diagnosis of cancer. Pathologists use the tumor’s appearance, cell division, and selected protein tests to distinguish it from malignant nerve tumors, while follow-up depends on its location and removal.

In this answer

3 sections

01

What Does “Cellular” Actually Mean?

02

How Pathologists Distinguish It From Cancer

03

Treatment and Follow-Up

Seeing the word “cellular” on a biopsy or pathology report can be frightening. It sounds like it might mean the cells are dividing out of control or that the tumor is turning into cancer. However, a cellular schwannoma is classified as a benign (non-cancerous) nerve tumor and is not expected to spread to other organs (metastasize) [1].

The term “cellular” simply describes how the tumor looks under a microscope. It means the Schwann cells inside the tumor are packed tightly together, rather than being loosely spaced out [1][2].

What Does “Cellular” Actually Mean?

Standard benign schwannomas are typically made up of two distinct patterns of tissue:

  • Antoni A areas: Regions where the cells are densely packed together.
  • Antoni B areas: Regions where the cells are loosely arranged with more fluid and space between them.

A cellular schwannoma is a rare variant (making up an estimated 2% to 6% of benign schwannomas) that is composed almost entirely of the dense Antoni A tissue [3][1]. Because the Antoni B areas are mostly missing and the cells are so tightly packed, the tumor is described as highly “cellular” by the pathologist [1][4].

How Pathologists Distinguish It From Cancer

Because the cells are so densely packed, a cellular schwannoma can sometimes mimic the microscopic appearance of a rare nerve cancer called a malignant peripheral nerve sheath tumor (MPNST) [1][5]. Seeing that MPNST was considered as a possibility on a report or during an online search can be terrifying, but the final diagnosis is what determines how the tumor is expected to behave.

Pathologists do not rely on a single test to make this diagnosis. They look at the complete picture: the overall microscopic pattern, whether the cells look atypical, the number of dividing cells (mitoses), and the clinical context [1]. They also often use immunohistochemical (IHC) tests, which detect specific proteins in the tissue, to help confidently distinguish cellular schwannoma from MPNST [6][1].

No single stain can prove a tumor is benign or malignant on its own, but pathologists look for a pattern:

Protein Marker What It Can Support What It Cannot Prove
H3K27me3 This protein is often retained (present) in cellular schwannomas, which is a reassuring sign [6][1]. In many MPNST cancers, it is completely lost [7]. Retained H3K27me3 does not absolutely guarantee the tumor is benign, as a subset of MPNSTs also retain it [6].
S100 and SOX10 These proteins are normally found in healthy Schwann cells and are typically strong and widespread in cellular schwannomas [6][1]. Because some MPNSTs also show these markers, their presence alone doesn’t rule out cancer [6].
Ki-67 Index This estimates the percentage of cells that are actively dividing. It can be slightly higher in cellular schwannomas than in standard schwannomas [3]. There is no universal Ki-67 cutoff that separates benign from malignant tumors; it is just one piece of the puzzle [3].

Note: Your report might not include every one of these markers. A biopsy sample may also not show the entire tumor, so an experienced soft-tissue or nerve pathologist will order only the tests needed to resolve any diagnostic questions.

Treatment and Follow-Up

While a cellular schwannoma is benign, its deep location (such as in the spine or the back of the abdomen) or its size can make it challenging to remove [8][4].

The primary goal of surgery is the complete, safe removal of the tumor while preserving nerve function. Surgeons may use nerve-sparing microsurgery techniques [3]. Sometimes, a surgeon will intentionally leave a small remnant of the tumor behind to avoid permanently damaging the nerve or nearby structures [1].

Because local recurrence (the tumor growing back in the exact same spot) is more closely associated with incomplete removal, follow-up depends heavily on your specific surgery [3][1]. There is no single imaging schedule for all patients. Your care team will recommend an individualized follow-up plan based on whether any tumor was left behind, the tumor’s location, and your symptoms.

Common questions in this guide

What does cellular schwannoma mean on a pathology report?
Cellular schwannoma is a rare benign nerve tumor made of tightly packed Schwann cells. The word cellular describes how the tumor looks under the microscope and does not mean that it is cancerous.
Is a cellular schwannoma a type of cancer?
No. Cellular schwannoma is classified as benign and is not expected to spread to other organs. Its dense appearance can resemble a malignant peripheral nerve sheath tumor, so the final diagnosis is based on the complete pathology assessment.
How do pathologists tell cellular schwannoma apart from MPNST?
Pathologists assess the tumor’s overall microscopic pattern, cell atypia, number of dividing cells, and clinical context. They may also use protein tests such as H3K27me3, S100, SOX10, and Ki-67, but no single test can by itself prove that a tumor is benign or malignant.
What treatment is used for cellular schwannoma?
When treatment is needed, surgery is the primary approach, with the goal of removing the tumor safely while preserving nerve function. A surgeon may use nerve-sparing microsurgery or intentionally leave a small remnant if complete removal could cause permanent damage.
Can cellular schwannoma grow back after surgery?
It can recur locally, and recurrence is more closely associated with incomplete removal. The recommended imaging schedule is individualized according to whether tumor remains, its location, the surgery performed, and your symptoms.
Should a specialist review my cellular schwannoma pathology report?
A review by a pathologist experienced in soft-tissue or peripheral nerve tumors may be helpful when the diagnosis is difficult or the tumor resembles a malignant nerve tumor. Ask whether your biopsy or excision was reviewed by an appropriate specialist.
What symptoms should I report after cellular schwannoma treatment?
Contact your care team about new or worsening pain, numbness, tingling, or weakness near the tumor site. Changes in bowel or bladder function should also prompt timely medical attention, especially when the tumor was near the spine or other important nerves.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was the tumor completely removed, or was a small piece intentionally left behind to protect the nerve?
  2. 2.What specific features on my pathology report led to the conclusion that this is a benign cellular schwannoma?
  3. 3.Was my biopsy or excision sample reviewed by a pathologist who specializes in soft-tissue or peripheral nerve tumors?
  4. 4.Given my specific surgery and whether any tumor remains, what should my imaging follow-up schedule look like?
  5. 5.What new or worsening symptoms—such as pain, numbness, weakness, or changes in bowel or bladder function—should prompt me to contact you immediately?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Vestibular Schwannoma: Will Facial & Hearing Improve?Do My Children Need Genetic Testing for My Schwannoma?Does Radiosurgery Shrink or Stop Schwannoma Growth?How Can I Manage Scanxiety During Schwannoma Surveillance?Why Does a Schwannoma Cause an Electric Shock Feeling?How Fast Do Benign Schwannomas Typically Grow Each Year?Why Can a Benign Schwannoma Cause Severe Pain and Weakness?Why Is Subtotal Resection Used for Schwannoma Surgery?Why Was NF2 Renamed to NF2-Related Schwannomatosis?

References

References (8)
  1. 1

    Intracranial cellular schwannomas: a clinicopathological study of 20 cases.

    D'Almeida Costa F, Dias TM, Lombardo KA, et al.

    Histopathology 2020; (76(2)):275-282 doi:10.1111/his.13967.

    PMID: 31379028
  2. 2

    Tongue Schwannoma: A Clinicopathologic Study of 19 Cases.

    Thompson LDR, Koh SS, Lau SK

    Head and neck pathology 2020; (14(3)):571-576 doi:10.1007/s12105-019-01071-9.

    PMID: 31485983
  3. 3

    Long-term postoperative outcomes of spinal cellular schwannoma: study of 93 consecutive cases.

    Jia Q, Lou Y, Chen D, et al.

    The spine journal : official journal of the North American Spine Society 2024; (24(5)):858-866 doi:10.1016/j.spinee.2024.01.006.

    PMID: 38272127
  4. 4

    Clinicopathological differences between classical schwannomas and cellular schwannomas in the retroperitoneum.

    Zhang X, Zheng H, Li G, Li T

    Journal of neuropathology and experimental neurology 2024; (83(12)):1030-1038 doi:10.1093/jnen/nlae104.

    PMID: 39340836
  5. 5

    Plexiform Cellular Schwannoma in Infancy and Childhood: A Clinicopathological Study of Seven Cases of an Underrecognized Nerve Sheath Tumor with a Tendency Toward Local Recurrence.

    Sun M, Shao M, Liu J, et al.

    International journal of surgical pathology 2022; (30(3)):265-272 doi:10.1177/10668969211052236.

    PMID: 34696615
  6. 6

    Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.

    Schaefer IM, Fletcher CD, Hornick JL

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016; (29(1)):4-13 doi:10.1038/modpathol.2015.134.

    PMID: 26585554
  7. 7

    CHD4 as a Potential Biomarker in Differentiating Between Cellular Schwannoma and Malignant Peripheral Nerve Sheath Tumor.

    Wu CC, Pan MR, Wei YC, et al.

    Applied immunohistochemistry & molecular morphology : AIMM 2018; (26(10)):775-780 doi:10.1097/PAI.0000000000000522.

    PMID: 28549031
  8. 8

    Comparison of pathological, radiological, and prognostic features between cellular schwannoma and non-cellular schwannoma.

    Zhu J, Yang Z, Tang R, Tang G

    European journal of radiology 2021; (141()):109783 doi:10.1016/j.ejrad.2021.109783.

    PMID: 34049057

This page is for informational purposes only and does not constitute medical advice. Your pathologist and treating surgeon should interpret your cellular schwannoma report and recommend follow-up for your situation.

Get notified when new evidence is published on Benign schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.